Innovative cryotherapy platform for the minimally invasive
ablation of various benign and malignant tumors.
Employees: 59
Market regions:
USA, Europe, Asia
Overview
GALIL MEDICAL is a medical device company that develops,
Click here to request more information, about this company (FOR COLLABORATION IN R&D. ONLY!)
Note - you have to be registered in this server to
request information. If you haven't done so
yet, please register in this server
Your requests will be forwarded to the developer, who
will contact you directly
You can also see the list of
documents you already requested more information about
manufactures and markets an innovative cryotherapy platform
incorporating powerful freezing technology and revolutionary
needle design as a minimally invasive alternative to surgery for
various clinical applications.
GALIL MEDICAL's cryotherapy platform has been widely used
worldwide for the treatment of prostate, and kidney cancer.
Building upon this success, the company is developing an expanded
product line to include systems targeted toward Women's Health
and Interventional Radiology applications.
The company's proprietary 17-gauge cryoablation needles, designed
for percutaneous insertion, generate precision iceballs for
targeted ablation. Integration with ultrasound, CT, or MR enables
a high level of control for needle placement and positioning,
iceball formation in real-time and the freezing process.
Real-time temperature monitoring controls impact to adjacent
healthy tissue.
GALIL MEDICAL, founded in 1996 by Rafael Development Corporation
Ltd (RDC), has headquarters, R&D and manufacturing facilities
based in Israel, and dedicated sales offices in the United States
and the United Kingdom.
